167 related articles for article (PubMed ID: 37541768)
1. Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial.
Landers JA; Mullany S; Craig JE
Br J Ophthalmol; 2024 May; 108(5):679-686. PubMed ID: 37541768
[TBL] [Abstract][Full Text] [Related]
2. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.
Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ
J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Cheng JW; Cheng SW; Wei RL; Lu GC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009782. PubMed ID: 26769010
[TBL] [Abstract][Full Text] [Related]
4. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
5. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Vahedian Z; Mafi M; Fakhraie G; Zarei R; Eslami Y; Ghadimi H; Mohebbi M
J Glaucoma; 2017 Sep; 26(9):829-834. PubMed ID: 28777224
[TBL] [Abstract][Full Text] [Related]
6. The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
Elgin U; Sen E; Ozdemir K; Ozdal P; Berker N
Int Ophthalmol; 2020 Apr; 40(4):795-802. PubMed ID: 31792855
[TBL] [Abstract][Full Text] [Related]
7. Prospective study comparing mitomycin C or bevacizumab as adjuvant in trabeculectomy revision by needling.
Franco L; Rassi B; Avila MP; Magacho L
Eur J Ophthalmol; 2016; 26(3):221-5. PubMed ID: 26449256
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
9. Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab.
Nilforushan N; Es'haghi A; Miraftabi A; Abolfathzadeh N; Banifatemi M
Br J Ophthalmol; 2022 May; 106(5):648-654. PubMed ID: 33328187
[TBL] [Abstract][Full Text] [Related]
10. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.
Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K
J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
13. Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study.
Rabina G; Barequet D; Mimouni M; Kurtz S; Shemesh G; Rosenblatt A; Rosenfeld E
Eur J Ophthalmol; 2020 Nov; 30(6):1356-1361. PubMed ID: 31496260
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
15. Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs.
Simsek T; Cankaya AB; Elgin U
J Ocul Pharmacol Ther; 2012 Oct; 28(5):542-6. PubMed ID: 22731246
[TBL] [Abstract][Full Text] [Related]
16. Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study.
José P; Teixeira FJ; Barão R; Sousa DC; Marques RE; Barata ADO; Marques-Neves C; Alves M; Papoila AL; Stalmans I; Silva JP; Abegão Pinto L
Br J Ophthalmol; 2022 Oct; 106(10):1399-1405. PubMed ID: 33931389
[TBL] [Abstract][Full Text] [Related]
17. Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.
Mahdy RA; Al-Mosallamy SM; Al-Aswad MA; Bor'i A; El-Haig WM
Eye (Lond); 2016 Jan; 30(1):53-8. PubMed ID: 26427987
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Liu X; Du L; Li N
Medicine (Baltimore); 2016 Apr; 95(15):e3223. PubMed ID: 27082560
[TBL] [Abstract][Full Text] [Related]
19. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial.
Fakhraie G; Ghadimi H; Eslami Y; Zarei R; Mohammadi M; Vahedian Z; Mafi M; Moghimi S
J Glaucoma; 2016 Mar; 25(3):e182-8. PubMed ID: 25493621
[TBL] [Abstract][Full Text] [Related]
20. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
